125 related articles for article (PubMed ID: 2695884)
1. [Treatment of sudden deafness of vascular etiology with venoruton].
Madej S
Otolaryngol Pol; 1989; 43(3):214-7. PubMed ID: 2695884
[TBL] [Abstract][Full Text] [Related]
2. Venoruton in the therapy of central retinal vein occlusion.
Zygulska-Mach H; Kostka-Trabka E; Kielar J; Grodzinska L; Dieron K; Kedzior A
Ther Hung; 1985; 33(2):79-82. PubMed ID: 3842005
[No Abstract] [Full Text] [Related]
3. Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.
Belcaro G; Rulo A; Candiani C
Vasa; 1989; 18(2):146-51. PubMed ID: 2662674
[TBL] [Abstract][Full Text] [Related]
4. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836
[No Abstract] [Full Text] [Related]
5. [Capillary resistance raising action of Venoruton. Experimental data on the therapeutic effects of Venoruton].
Gábor M
Acta Pharm Hung; 1983 May; 53(3):115-20. PubMed ID: 6880764
[No Abstract] [Full Text] [Related]
6. [Venoruton and capillary permeability].
Cesarone MR; Laurora G; Gabini M; Errichi BM; Candiani C; Belcaro G
Minerva Cardioangiol; 1989 May; 37(5):265-8. PubMed ID: 2779806
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of capillary permeability and microcirculation in patients with chronic venous hypertension treated with venoruton by the vacuum suction chamber (VSC) device and laser-Doppler flowmetry.
Belcaro G; D'Aulerio A; Rulo A; Candiani C
Phlebologie; 1988; 41(4):847-56. PubMed ID: 3073400
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study].
Artaria LG
Klin Monbl Augenheilkd; 1982 Jun; 180(6):568-70. PubMed ID: 6752553
[No Abstract] [Full Text] [Related]
9. Anticatatonic effect of venoruton.
Aley KO; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):263-5. PubMed ID: 2898576
[TBL] [Abstract][Full Text] [Related]
10. [Parieval in 52 cases of internal ear deafness].
Martin H; Oudot J
Ann Otolaryngol Chir Cervicofac; 1980 Dec; 97(12):1073-9. PubMed ID: 7247212
[No Abstract] [Full Text] [Related]
11. [Clinical, placebo-controlled double-blind study of venoruton in the treatment of chronic venous insufficiency. Importance of the selection of patients].
Balmer A; Limoni C
Vasa; 1980; 9(1):76-82. PubMed ID: 7368843
[No Abstract] [Full Text] [Related]
12. Effects of Troxerutin on the hemorheological parameters of patients with moderate arterial hypertension.
Gueguen-Duchesne M; Durand F; Le Goff MC; Genetet B
Prog Clin Biol Res; 1988; 280():401-6. PubMed ID: 3174703
[No Abstract] [Full Text] [Related]
13. [Pharmacolymphography with Venalot and Venoruton--a 7 years' report].
Schmidt F; Keilacker M
Radiol Diagn (Berl); 1985; 26(1):41-51. PubMed ID: 3991896
[No Abstract] [Full Text] [Related]
14. [Effect of Venoruton on the lower-leg volume in normal persons and in patients with venous-flow disorders].
Bopp J
Med Welt; 1977 Oct; 28(41):1660-4. PubMed ID: 927128
[No Abstract] [Full Text] [Related]
15. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK.
Pulvertaft TB
Vasa; 1983; 12(4):373-6. PubMed ID: 6362258
[No Abstract] [Full Text] [Related]
16. [Venalot used in therapy of phlebopathies].
Lacativa AS
Med Welt; 1980 May; 31(19):727-9. PubMed ID: 7421506
[No Abstract] [Full Text] [Related]
17. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
Lukjan H; Rość D; Chyzy R; Bodzenta A; Szpak A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865
[TBL] [Abstract][Full Text] [Related]
18. Comparative investigations on the treatment of the varicose syndrome with 4-methyl-6,7-(bis-beta-diethyl-aminoethoxy)-coumarine hydrochloride (oxamarine), with the disodium salt of disulphuric ester of 4-methyl-aesculetol and with tri-hydroxy-ethylrutoside (troxerutin).
Frandoli G; Turazza G; Spreafico PL
Panminerva Med; 1972 Sep; 14(9):290-5. PubMed ID: 4618898
[No Abstract] [Full Text] [Related]
19. Benzo-pyrones in the treatment of chronic schizophrenic diseases.
Casley-Smith JR; Casley-Smith JR; Johnson AF; Weston FK
Psychiatry Res; 1986 Jul; 18(3):267-73. PubMed ID: 2875479
[TBL] [Abstract][Full Text] [Related]
20. [Piracetam infusions in acute tinnitus and sudden deafness].
Gutmann R; Mees K
Fortschr Med; 1995 Jun; 113(18):288-90. PubMed ID: 7657193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
